Petros Pharmaceuticals, Inc. (PTPI)
0.0042
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Petros Pharmaceuticals Enterprise Value : -3.311M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | -3.311M |
| August 21, 2026 | -3.308M |
| August 20, 2026 | -3.340M |
| August 19, 2026 | -3.323M |
| August 18, 2026 | -3.37M |
| August 17, 2026 | -3.374M |
| August 14, 2026 | -3.374M |
| August 13, 2026 | -3.344M |
| August 12, 2026 | -3.353M |
| August 11, 2026 | -3.353M |
| August 10, 2026 | -3.351M |
| August 07, 2026 | -3.353M |
| August 06, 2026 | -3.362M |
| August 05, 2026 | -3.383M |
| August 04, 2026 | -3.378M |
| August 03, 2026 | -3.359M |
| July 31, 2026 | -3.362M |
| July 30, 2026 | -3.336M |
| July 29, 2026 | -3.336M |
| July 28, 2026 | -3.319M |
| July 27, 2026 | -3.319M |
| July 24, 2026 | -3.319M |
| July 23, 2026 | -3.319M |
| July 22, 2026 | -3.319M |
| July 21, 2026 | -3.319M |
| Date | Value |
|---|---|
| July 20, 2026 | -3.296M |
| July 17, 2026 | -3.296M |
| July 16, 2026 | -3.302M |
| July 15, 2026 | -3.294M |
| July 14, 2026 | -3.310M |
| July 13, 2026 | -3.277M |
| July 10, 2026 | -3.281M |
| July 09, 2026 | -3.294M |
| July 08, 2026 | -3.306M |
| July 07, 2026 | -3.288M |
| July 06, 2026 | -3.281M |
| July 02, 2026 | -3.277M |
| July 01, 2026 | -3.272M |
| June 30, 2026 | -3.272M |
| June 29, 2026 | -4.107M |
| June 26, 2026 | -4.101M |
| June 25, 2026 | -4.098M |
| June 24, 2026 | -4.098M |
| June 23, 2026 | -4.107M |
| June 22, 2026 | -4.102M |
| June 18, 2026 | -4.096M |
| June 17, 2026 | -4.098M |
| June 16, 2026 | -4.100M |
| June 15, 2026 | -4.096M |
| June 12, 2026 | -4.056M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 174.94M |
| Orthofix Medical, Inc. | 556.24M |
| ResMed, Inc. | 32.88B |
| Rockwell Medical, Inc. | 20.51M |
| Microbot Medical, Inc. | 31.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.9556M |
| Total Expenses (Quarterly) | 0.9556M |
| EPS Diluted (Quarterly) | -0.3038 |
| Earnings Yield | -7.49K% |
| Normalized Earnings Yield | -7492.86 |